The Journal of Organic Chemistry
Article
of 22a from 21a. Colorless oil: [α] 20 +3.5° (c 0.47, CHCl ); IR (film)
thoxy)-2,4,6,8-tetramethyldec-8-enoyl]oxazolidin-2-one (24b) (8 mg,
D
3
νmax 2929, 2857, 1458, 1380, 1256, 1147, 1101, 1037, 919, 836, 775
0.015 mmol) was dissolved in dry CH Cl under argon atmosphere
2
2
−1 1
cm ; H NMR (400 MHz, CDCl ) δ 5.32 (t, J = 6.8 Hz, 1H), 4.72 (s,
(0.6 mL). A solution of sodium methoxide (0.5 M solution in MeOH,
0.03 mL, 0.015 mmol) was added, and the reaction was stirred at 0 °C
for 5 min. The reaction was quenched with saturated ammonium
chloride (0.5 mL) and CH Cl was added (3 mL). The organic layer
3
2
3
1
1
H), 4.62 (s, 2H), 4.07 (d, J = 6.8, Hz, 2H), 3.51 (d, J = 10.0, Hz, 1H),
.45 (d, J = 10.0, Hz, 1H), 3.36 (s, 3H), 3.34 (s, 3H), 2.15 (dd, J =
2.8, 5.0 Hz, 1H), 1.89−1.80 (m, 1H), 1.78 (dd, J = 12.8, 9.2 Hz, 1H),
.64 (s, 3H), 1.54 (dd, J = 14.6, 4.2 Hz, 1H), 1.31 (dd, J = 14.6, 6.6
2
2
was washed with brine (1 mL), dried over anhydrous sodium sulfate
and filtered. The solvent was evaporated under reduced pressure to
give the ester 26b (1.8 mg, 32%). Colorless oil: [α]D20 −51.8° (c 0.1,
CHCl ); IR (film) ν 3439, 2921, 1731, 1455, 1380, 1211, 1034, 746
13
Hz, 1H), 1.20 (s, 3H), 0.88 (m, 12H), 0.03 (s, 6H); C NMR (100
MHz, CDCl ) δ 139.8, 121.9, 95.4, 91.2, 79.0, 68.7, 63.6, 55.3, 55.2,
3
4
9.3, 43.2, 26.0, 25.9 (3C), 21.8, 21.4, 18.2, 16.1, −5.5 (2C); HRMS
3
max
+
+
−1 1
(
ESI ) calcd for C H O NaSi [M + Na] 427.2856, found 427.2851.
cm ; H NMR (500 MHz, CDCl ) δ 5.32 (t, J = 6.5 Hz, 1H), 4.64 (d,
21
44
5
3
Preparation of (2S,4R,6E)-2,8-Bis(methoxymethoxy)-2,4,6-
J = 7.5, Hz, 1H), 4.63 (d, J = 7.5, Hz, 1H), 4.61 (s, 2H), 4.07 (d, J =
6.5, Hz, 2H), 3.71 (d, J = 9.5 Hz, OH), 3.67 (s, 3H), 3.44 (dd, J = 9.5,
2.5 Hz, 1H), 3.36 (s, 3H), 3.32 (s, 3H), 2.77 (dq, J = 7.5, 2.5 Hz, 1H),
2.10 (dd, J = 13.0, 6.0 Hz, 1H), 1.82 (dd, J = 13.0, 8.5 Hz, 1H), 1.72−
1.64 (m, 2H), 1.63 (s, 3H), 1.49 (dd, J = 13.0, 3.5 Hz, 1H), 1.32 (d, J
= 7.5 Hz, 3H), 1.25 (s, 3H), 0.91 (d, J = 6.0 Hz, 3H); 13C NMR (125
trimethyloct-6-en-1-ol (23b). (2S,4R,6E)-1-(tert-Butyldimethylsily-
loxy)-2,8-bis(methoxymethoxy)-2,4,6-trimethyl oct-6-ene (22b)
(
(
9
950.0 mg, 2.35 mmol) was converted to (2S,4R,6E)-2,8-bis-
methoxymethoxy)-2,4,6-trimethyloct-6-en-1-ol (23b) (626.8 mg,
2%) following the methodology described above for the synthesis
2
0
of 22a from 23a. Colorless oil: [α]D +9.8° (c 0.75, CHCl ); IR (film)
max
MHz, CDCl ) δ 176.9, 139.4, 122.4, 95.4, 91.1, 81.3, 79.2, 63.5, 55.5,
3
3
−
1
+
ν
3473, 2928, 1645, 1449, 1384, 1212, 1147, 1093, 1032, 918 cm ;
55.2, 51.5, 49.4, 42.5, 38.7, 26.6, 21.6, 20.2, 17.0, 16.1; HRMS (ESI )
1
+
H NMR (500 MHz, CDCl ) δ 5.32 (t, J = 6.8 Hz, 1H), 4.69 (d, J =
calcd for C H O Na [M + Na] 399.2359, found 399.2351.
3
19 36
7
7
.5 Hz, 1H), 4.65 (d, J = 7.5 Hz, 1H), 4.62 (s, 2H), 4.07 (d, J = 6.8,
Deprotection of Compound 24b with PPTS. A solution of
pyridinium p-toluenesulfonate (PPTS, 31.1 mg, 0.12 mmol) in t-
BuOH (2 mL) was added to a solution of (4S,2′R,3′S,4′S,6′R,8′E)-4-
benzyl-3-[3-hydroxy-4,8-bis(methoxymethoxy)-2,4,6,8-tetramethyldec-
8-enoyl]oxazolidin-2-one (24b) (29.4 mg, 0.06 mmol) at 80 °C and
stirred for 12 h. Then, saturated sodium bicarbonate (1 mL) was
added and stirred for 10 min. Water (3 mL) and ethyl acetate (10 mL)
were added, and the aqueous layer was separated and extracted with
three portions of ethyl acetate (10 mL). The combined organic
solution was washed with brine (10 mL), dried over anhydrous sodium
sulfate and filtered. Evaporation of the solvent gave a crude product
that was purified by silica gel column chromatography. Elution with
petroleum ether:ethyl acetate (60:40) yielded the lactones 25b (3.7
mg, 23%) and 3b (8.8 mg, 65%).
Hz, 2H), 3.45 (dd, J = 12.5, 6.5, Hz, 1H), 3.40 (s, 3H), 3.37 (s, 3H),
3
.35 (dd, J = 12.5, 8.0 Hz, 1H), 3.26 (dd, J = 8.0, 6.5 Hz, OH), 2.12
(
(
dd, J = 17.5, 10.0 Hz, 1H), 1.86−1.78 (m, 2H), 1.63 (s, 3H), 1.60
dd, J = 14.6, 4.0 Hz, 1H), 1.23 (dd, J = 14.6, 6.0 Hz, 1H), 1.20 (s,
3
1
2
H), 0.90 (d, J = 6.0 Hz, 3H); 13C NMR (125 MHz, CDCl ) δ 139.6,
3
22.3, 95.5, 90.7, 79.9, 68.7, 63.5, 55.4, 55.2, 49.1, 42.7, 26.0, 21.9,
+
+
0.4, 16.1; HRMS (ESI ) calcd for C H O Na [M + Na] 313.1991,
15 30 5
found 313.1990.
Preparation of (2S,4R,6E)-2,8-Bis(methoxymethoxy)-2,4,6-
trimethyloct-6-enal (8b). (2S,4R,6E)-2,8-Bis(methoxymethoxy)-
2
converted to (2S,4R,6E)-2,8-bis(methoxymethoxy)-2,4,6-trimethy-
loct-6-enal (8b) (171.0 mg, 89.5%) following the methodology
described above for the synthesis of 8a from 23a. Colorless oil: [α]D
−
1
,4,6-trimethyloct-6-en-1-ol (23b) (192.3 mg, 0.66 mmol) was
20
(3R,4S,5S,2′R,4′E)-4-Hydroxy-5-(6-(methoxymethoxy)-2,4-di-
12.0° (c 0.42, CHCl ); IR (film) ν 2928, 2720, 1732, 1455, 1378,
methylhex-4-enyl)-3,5-dimethyl-4,5-dihydrofuran-2(3H)-one
3
max
−1
1
20
215, 1148, 1103, 1038, 919 cm ; H NMR (500 MHz, CDCl ) δ
(25b). Colorless oil: [α]
D
−2.8° (c 0.16, CHCl ); IR (film) νmax
3
3
−
1 1
9
.53 (s, 1H), 5.32 (t, J = 7.0 Hz, 1H), 4.76 (d, J = 7.0 Hz, 1H), 4.62 (d,
3443, 2940, 1750, 1456, 1383, 1215, 1147, 1099, 1037, 934 cm ; H
NMR (500 MHz, CDCl ) δ 5.33 (t, J = 6.8 Hz, 1H), 4.61 (s, 2H), 4.08
J = 7.0 Hz, 1H), 4.61 (s, 2H), 4.07 (d, J = 7.0, Hz, 2H), 3.39 (s, 3H),
3
3
.36 (s, 3H), 2.07 (dd, J = 16.4, 10.0 Hz, 1H), 1.86−1.78 (m, 2H),
(dd, J = 11.6, 6.8 Hz, 1H), 4.05 (dd, J = 11.6, 6.8 Hz, 1H), 4.01 (d, J =
5.4 Hz, 1H), 3.36 (s, 3H), 2.93 (dq, J = 7.2, 5.4 Hz, 1H), 2.15 (dd, J =
12.1, 4.9 Hz, 1H), 1.92−1.84 (m, 3H), 1.66 (s, 3H), 1.56 (dd, J = 14.1,
1
.69 (dd, J = 14.8, 4.2 Hz, 1H), 1.62 (s, 3H), 1.44 (dd, J = 14.8, 7.0
13
Hz, 1H), 1.30 (s, 3H), 0.87 (d, J = 6.5 Hz, 3H); C NMR (125 MHz,
CDCl ) δ 203.5, 139.0, 122.6, 95.5, 91.9, 82.6, 63.5, 55.8, 55.2, 48.8,
4
6.4 Hz, 1H), 1.34 (s, 3H), 1.22 (d, J = 7.2 Hz, 3H), 0.95 (d, J = 6.2 Hz,
3
+
13
2.6, 26.1, 21.3, 18.2, 16.0; HRMS (ESI ) calcd for C H O Na [M +
3H); C NMR (125 MHz, CDCl
3
) δ 177.6, 139.4, 122.4, 95.4, 87.7,
15
28
5
+
Na] 311.1834, found 311.1837.
76.4, 63.7, 55.2, 48.4, 40.4, 40.0, 26.6, 22.9, 21.4, 16.2, 8.3; HRMS
+
+
Preparation of (4S,2′R,3′S,4′S,6′R,8′E)-4-Benzyl-3-[3-hy-
droxy-4,8-bis(methoxymethoxy)-2,4,6,8-tetramethyldec-8-
enoyl]oxazolidin-2-one (24b). (2S,4R,6E)-2,8-Bis(methoxymeth-
oxy)-2,4,6-trimethyloct-6-enal (8b) (170.0 mg, 0.59 mmol) was
converted to (4S,2′R,3′S,4′S,6′R,8′E)-4-benzyl-3-[3-hydroxy-4,8-bis-
(ESI ) calcd for C H O Na [M + Na] 323.1834, found 323.1834.
16 28 5
(3R,4S,5S,2′R,4′E)-4-Hydroxy-5-(6-hydroxy-2,4-dimethylhex-
4-enyl)-3,5-dimethyl-4,5-dihydrofuran-2(3H)-one (3b). Color-
less oil: [α]D20 −2.5° (c 0.2, CHCl ); IR (film) ν
3433, 2931,
3
max
−1 1
1742, 1451, 1361, 1210, 1090, 1018, 936 cm ; H NMR (500 MHz,
(
methoxymethoxy)-2,4,6,8-tetra-methyldec-8-enoyl]oxazolidin-2-one
CDCl ) δ 5.41 (t, J = 7.0 Hz, 1H), 4.17 (dd, J = 12.0, 7.0 Hz, 1H),
3
(24b) (223.5 mg, 72.5% yield, 95% de) following the methodology
4.12 (dd, J = 12.0, 7.0 Hz, 1H), 4.03 (d, J = 5.5 Hz, 1H), 2.94 (dq, J =
7.2, 5.5 Hz, 1H), 2.15 (dd, J = 12.2, 5.2 Hz, 1H), 1.93−1.85 (m, 3H),
20
described above for the synthesis of 24a from 8a. Colorless oil: [α]D
+
1
5.5° (c 0.27, CHCl ); IR (film) νmax 3457, 2930, 1781, 1673, 1460,
1.66 (s, 3H), 1.55 (dd, J = 15.8, 8.0 Hz, 1H), 1.35 (s, 3H), 1.24 (d, J =
3
−1
1
13
384, 1208, 1147, 1105, 1030, 919 cm ; H NMR (500 MHz,
7.5 Hz, 3H), 0.96 (d, J = 6.2 Hz, 3H); C NMR (125 MHz, CDCl ) δ
3
CDCl ) δ 7.36−7−32 (m, 2H), 7.29−7.24 (m, 3H), 5.33 (t, J = 6.8
177.6, 138.4, 125.4, 87.6, 76.5, 59.3, 48.3, 40.4, 40.0, 26.6, 22.8, 21.5,
3
+
+
Hz, 1H), 4.66−4.59 (m, 5H), 4.36 (dq, J = 7.2, 2.6 Hz, 1H), 4.14 (m,
16.2, 8.3; HRMS (ESI ) calcd for C H O Na [M + Na] 279.1572,
14 24 4
2
H), 4.07 (d, J = 6.8, Hz, 2H), 3.61 (br s, 1H), 3.45 (dd, J = 13.2, 3.0
found 279.1563.
Hz, 1H), 3.37 (s, 3H), 3.30 (s, 3H), 2.60 (dd, J = 13.2, 10.8 Hz, 1H),
.16 (dd, J = 13.0, 5.2 Hz, 1H), 1.83 (dd, J = 13.0, 9.0 Hz, 1H), 1.78
dd, J = 13.0, 6.0 Hz, 1H), 1.74−1.69 (m, 1H), 1.65 (s, 3H), 1.54 (dd,
J = 13.0, 4.0 Hz, 1H), 1.38 (d, J = 7.2 Hz, 3H), 1.32 (s, 3H), 0.92 (d, J
6.4 Hz, 3H); 13C NMR (125 MHz, CDCl ) δ 178.3, 152.9, 139.5,
Preparation of (3R,4S,5S,2′R,4′E)-5-[6-((R)-Methoxyphenyla-
cetoxy)-2,4-dimethylhex-4-enoyl]-4-((R)-methoxyphenylace-
toxy)-3,5-dimehtyldihydrofuran-2(3H)-one (27b).
(3R,4S,5S,2′R,4′E)-4-Hydroxy-5-(6-hydroxy-2,4-dimethylhex-4-enyl)-
3,5-dimethyl-4,5-dihydrofuran-2(3H)-one (3b) (1.2 mg, 4.7 μmol)
was converted to compound 27b (2.2 mg, 86.0%) following the
2
(
=
3
1
35.5, 129.3 (2C), 129.0 (2C), 127.3, 122.3, 95.4, 90.8, 81.8, 81.0,
6
1
5.8, 63.5, 55.6, 55.2, 55.1, 49.4, 42.4, 38.0, 34.6, 26.7, 21.6, 20.9, 17.9,
methodology described above for the synthesis of 7 from 5.
+
+
20
6.1; HRMS (ESI ) calcd for C H NO Na [M + Na] 544.2886,
Amorphous solid: [α]
D
−47.5° (c 0.13, CHCl ); IR (film) υmax
3
28
43
8
1
found 544.2901.
2925, 1770, 1723, 1453, 1253, 1172, 1108, 1023, 759; H NMR (600
MHz, CD Cl ) δ 7.33−7.27 (m, 10H), 5.18 (d, J = 6.0, 1H), 5.16 (t, J
= 7.0 Hz, 1H), 4.69 (s, 1H), 4.61 (s, 1H), 4.51 (d, J = 6.6 Hz, 1H),
3.33 (s, 3H), 3.31 (s, 3H), 2.81 (dq, J = 7.2, 5.9 Hz, 1H), 2.11 (dd, J =
Preparation of (2R,3S,4S,6R,8E)-Allyl 3-hydroxy-4,10-bis-
methoxymethoxy)-2,4,6,8-tetramethylnon-8-enoate (26b).
2
2
(
(
4S,2′R,3′S,4′S,6′R,8′E)-4-Benzyl-3-[3-hydroxy-4,8-bis(methoxy me-
I
dx.doi.org/10.1021/jo501471m | J. Org. Chem. XXXX, XXX, XXX−XXX